Male Infertility Market Size

Male Infertility Market Size

Male Infertility Market size was valued at around USD 4 billion in 2023 and is estimated to grow at 4.7% CAGR from 2024 to 2032. Male infertility occurs when a man is unable to impregnate a fertile female partner despite consistent, unprotected intercourse over an extended period.

To get key market trends

  Download Free Sample

Typically, it's diagnosed after ruling out potential female infertility causes. Male infertility can stem from various factors, such as sperm production or function issues, structural abnormalities in the reproductive system, hormonal imbalances, genetic predispositions, infections, or environmental influences.
 

The growth in assisted reproductive technologies is a significant driver for the market. The assisted reproductive technologies procedures have revolutionized fertility treatments and have offered hope to couples facing infertility challenges. Assisted reproductive technologies encompass a range of medical procedures designed to facilitate conception when natural conception is not possible or successful. The increasing need for ART stems from factors such as delayed childbearing, rising infertility rates, and advancements in medical technology.
 

According to the Centers for Disease Control and Prevention (CDC), in 2021, fertility clinics in the U.S. performed 413,776 assisted reproductive technologies cycles, resulting in 91,906 live births and 97,128 live-born infants, with 167,689 cycles dedicated to egg or embryo banking for future use. Therefore, this underscore assisted reproductive technology’s pivotal role in helping individuals achieve parenthood despite reproductive challenges.
 

Furthermore, advancements in diagnostic technologies, growth in assisted reproductive technology, which is estimated to reach USD 62.8 billion by 2032, increasing research and development in fertility treatments, rising awareness and education, are the promoting factors advancing the growth of the market.